Literature DB >> 24080140

Treatment outcomes of sinonasal adenoid cystic carcinoma: 30 cases from a single institution.

Sang Yeob Seong1, Dong Woo Hyun2, Yoo Suk Kim3, Hyung-Ju Cho4, Jeung-Gweon Lee4, Joo-Heon Yoon4, Chang-Hoon Kim5.   

Abstract

OBJECTIVE: To establish the clinical features and prognostic factors of sinonasal adenoid cystic carcinoma (ACC).
MATERIAL AND METHODS: Thirty patients with histopathological diagnosis of sinonasal ACC who were treated at Severance Hospital between 1990 and 2010 were included in this retrospective chart review study.
RESULTS: The 5-year disease-specific survival and disease-free survival rates were 75.3% and 37.2%, respectively. The maxillary sinus (63.3%) and nasal cavity (23.3%) were the most common sites of primary tumour. Most patients were diagnosed with advanced-stage (III/IV) disease (80.0%) and had undergone surgery and postoperative radiotherapy (70.0%). The most common histopathological subtype was cribriform type (40.9%). Local recurrence rate and distant metastasis rates were 26.7% and 23.3%, respectively. The mean time from primary treatment to recurrence was 44.5 months. Sinonasal ACC patients with stage IV and T4 disease had significantly worse survival than those with low stage and T disease. Patients with local recurrence had worse disease-specific survival than those with distant recurrence. Distant metastasis was associated with disease-free survival but not disease-specific survival.
CONCLUSION: Despite the frequent occurrence of distant metastasis, early diagnosis and effective local control seemed to be the most important factors influencing the survival of sinonasal ACC.
Copyright © 2013 European Association for Cranio-Maxillo-Facial Surgery. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Adenoid cystic carcinoma; Nasal cavity; Paranasal sinus; Prognostic factors; Survival

Mesh:

Year:  2013        PMID: 24080140     DOI: 10.1016/j.jcms.2013.08.002

Source DB:  PubMed          Journal:  J Craniomaxillofac Surg        ISSN: 1010-5182            Impact factor:   2.078


  5 in total

Review 1.  Applications of molecular testing in surgical pathology of the head and neck.

Authors:  Jennifer L Hunt
Journal:  Mod Pathol       Date:  2017-01       Impact factor: 7.842

Review 2.  Cervical lymph node metastasis in adenoid cystic carcinoma of the sinonasal tract, nasopharynx, lacrimal glands and external auditory canal: a collective international review.

Authors: 
Journal:  J Laryngol Otol       Date:  2016-11-14       Impact factor: 1.469

3.  Phosphorylated epidermal growth factor receptor expression and KRAS mutation status in salivary gland carcinomas.

Authors:  T Schneider; A Strehl; C Linz; R Brands; S Hartmann; F Beckford; A Rosenwald; A C Kübler; U D A Müller-Richter
Journal:  Clin Oral Investig       Date:  2015-08-06       Impact factor: 3.573

4.  Cavernous sinus involvement is not a risk factor for the primary tumor site treatment outcome of Sinonasal adenoid cystic carcinoma.

Authors:  Yi-Chan Lee; Ta-Jen Lee; Ngan-Ming Tsang; Yenlin Huang; Cheng-Lung Hsu; Li-Jen Hsin; Yi-Hsuan Lee; Kai-Ping Chang
Journal:  J Otolaryngol Head Neck Surg       Date:  2018-02-05

5.  Laryngeal adenoid cystic carcinoma: Three cases reports.

Authors:  Yu Cui; Lirong Bi; Le Sun; Xin Wang; Zhanpeng Zhu
Journal:  Medicine (Baltimore)       Date:  2019-12       Impact factor: 1.889

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.